About Lung Cancer
Lung cancer is the leading cause of cancer deaths in the United States and worldwide. Approximately 85% of lung cancer occurs in current or former tobacco smokers. Lung cancer forms in the tissues of the lungs, usually in the cells lining air passages. The two most common types are small cell lung cancer and non-small cell lung cancer. Lung cancer that is detected early, before it spreads (metastasizes) to other parts of the body, can be more successfully treated.
Screening examinations are tests performed to find disease before symptoms begin. The goal of any screening is to detect disease at its earliest and most treatable stage. Current recommendations for lung cancer screening are based on risk factors for lung cancer. Lung cancer risk factors include: smoking tobacco; exposure to radon, asbestos or other cancer-causing agents; family history of lung cancer; personal history of a smoking related cancer; certain chronic lung diseases.
Who is Eligible?
Individuals at an increased risk of developing lung cancer should meet the following criteria:
- 55-77 years old with 30 pack years smoking history*
- Current smoker or one who has quit within the last 15 years
- No symptoms of lung cancer and willing and able to undergo treatment if necessary
*To calculate pack years multiply years smoked x average packs/day smoked
Potential Screening Benefits: Effective research proven screening exam; early diagnosis which can lead to improved outcomes; non-invasive testing; decreased radiation exposure.
Potential Screening Risks: False positive test results; false negative test results; finding late-stage cancer; overtreatment including additional tests or procedures; radiation exposure.
How it works
Computed tomography (CT) scanning combines special x-ray equipment with sophisticated computers to produce pictures of the inside of the body. Low-dose CT (LDCT) scans produce images of sufficient quality to detect many lung diseases or abnormalities but use up to 70% less radiation than a regular CT scan. The scan is normally performed while lying on your back on a table. No IV or oral contrast medications are required for LDCTs.
Greenville Health System (GHS) has a comprehensive lung cancer screening program housed at both the Cancer Institute’s Center for Integrative Oncology & Survivorship (CIOS) and the GHS Lung Center. Nurse practitioners (NPs) and staff work closely with physicians and staff of GHS Outpatient Radiology (Faris Road only) along with GHS Thoracic Surgery and other UMG specialists to provide comprehensive screening, risk reduction, and follow-up care for referred patients.
Below are current statistics of findings through the CIOS Lung Cancer Screening program
Lung Cancer Alliance
The Cancer Institute’s Center for Integrative Oncology and Survivorship of Greenville Health System has been named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening. This center is one of five in the state of South Carolina and of the 250 nationally recognized sites.
LCA is a leading non-profit organization dedicated to saving lives and advancing research by empowering people living with or at risk for lung cancer. LCA provides live, professional support, referral and information services to patients, their loved ones, and those at risk for lung cancer and conducts national awareness campaigns. Please visit the website for more information on the alliance at www.lungcanceralliance.org.
GHS has been designated a Lung Cancer Screening Center by the American College of Radiology (ACR). The ACR Lung Cancer Screening Center designation is a voluntary program that recognizes facilities that have committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer.
In order to receive this elite distinction, facilities must be accredited by the ACR in computed tomography in the chest module, as well as undergo a rigorous assessment of its lung cancer screening protocol and infrastructure. Also required are procedures in place for follow-up patient care, such as counseling and smoking cessation programs.
Scheduling a Visit
Patients can schedule an appointment by calling 1-844-GHS-DOCS (447-3627) or by contacting one of the following locations:
- Center for Integrative Oncology and Survivorship (CIOS)
900 W. Faris Road
- GHS Lung Center
200 Patewood Dr., Suite B-300